The independent source for health policy research, polling, and news.
121 - 140 of 112,763 Results
Rep. Robert Garcia (D-Calif.) has requested documents from Taylor Farms, the White House, the FDA, and the CDC that could shed light on reports that company executives and government officials sought "to distance the company from the outbreak and cast doubt on the officials’ conclusion," The Hill reported.
Today's early morning highlights from the major news organizations.
Editorial writers discuss these public health issues.
And the death toll is likely higher, experts told The Washington Post, because of the United States’ slow and sometimes haphazard approach to assessing deaths from extreme temperatures.
Politico reports that Students for Life of America spent two years analyzing water samples in different American cities. They have released a report that purports to show “significant levels of mifepristone” in the waterways of Austin, Texas; Blacksburg, Virginia; and Carbondale, Illinois. Several environmental experts told Politico that there are flaws in the study’s methodology and its conclusions are “misleading."
Last week, OpenAI released Health in ChatGPT, allowing users to upload their medical records and connect them to Apple Health.
Demand for food-is-medicine programs is rising as the Supplemental Nutrition Assistance Program, or SNAP, prepares for an estimated $186 billion in federal funding cuts over the next decade, Modern Healthcare reports. Other news on healthcare costs is on a rise in those who are uninsured, the 340B program, and more.
The FDA’s Pharmacy Compounding Advisory Committee approved the peptides epitalon and semax for compounding, but not everyone thinks it's a good idea. Experts say this move might lead people to think the FDA has thoroughly evaluated these compounds, NBC News reported, when it has not. “At stake is literally the future of the FDA drug approval process,” one doctor said.
A little more than halfway through the year, the United States has already confirmed more cases — 2,318 — than it had in 2025. Public health experts say a full-throated vaccination push at the national level would stem the tide in cases but acknowledge that seems unlikely under the current administration. Plus, the latest on rising cyclosporiasis cases.
Today's early morning highlights from the major news organizations.
Opinion writers tackle these public health topics.
Each week, KFF Health News finds longer stories for you to enjoy. Today's selections are on epidemics, fat phobia, bathroom bans, and more.
A Texas appeals court overturned an injunction closing a Houston midwife's clinics after finding that Texas Attorney General Ken Paxton's office used an anonymous email as the only evidence, The Texas Tribune reported.
Health and Human Services has eliminated reporting requirements for the Advisory Commission on Childhood Vaccines and moved away from having a "federal official responsible for ACCV oversight." The National Vaccine Advisory Committee has been directed to consider "non-immunization strategies." The changes indicate the White House isn't "putting the brakes on Sec. Kennedy's mission to undermine immunization," one former NVAC panelist said.
“I’m confident that she knows what she is doing and will stand against those who do not,” Republican Sen. Bill Cassidy of Louisiana said of Erica Schwartz. With Cassidy’s nod, The New York Times reported, it appears likely that the health committee will approve Schwartz’s nomination, teeing up a vote in the full Senate.
The study, published in JAMA Pediatrics, found that many first-line treatments became ineffective over the past two decades. “There’s really no area of the world that isn’t seeing an increase” in resistance, one researcher said.
The agency has filed an appeal to reverse a court's decision last month that invalidated portions of a program integrity rule issued in 2025. Among the disputed portions were a $5 penalty for automatic reenrollments and a shortened enrollment period for the 2027 plan year, Fierce Healthcare reported.
An advisory panel recommended that compounding pharmacies be allowed to manufacture the drugs BPC-157, KPV, TB-500, and MOTS-c, Stat reported. The advisers will consider more compounds today. The recommendation is a win for Health Secretary Robert F. Kennedy Jr., but the FDA must still make the final approval.
Today's early morning highlights from the major news organizations.
Editorial writers examine these public health issues.
© 2026 KFF